Drug-Drug Interactions (DDI) Archives

Publication

Population Pharmacokinetics and Exposure-Response Analysis of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia Patients With NPM1 Mutation

This study evaluated how the leukemia drug ziftomenib behaves in the body and whether different…

CertaraMay 7, 2026

Fact Sheet

DIDB® Concomitant Meds Navigator

Explore the Concomitant Meds Navigator withing DIDB - An evidence-based tool within DIDB that helps…

CertaraApril 27, 2026

Blog

Regulatory horizons 2026: clinical pharmacology strategy and regulatory expectations

Learn how regulatory expectations in clinical pharmacology are evolving and how to build a strategy…

CertaraMarch 24, 2026

Blog

What is Simcyp Discovery and How Does it Support Drug Discovery?

Learn how Simcyp helps in drug discovery, supporting compound selection, first-in-human PK prediction, early DDI…

CertaraMarch 3, 2026

Conference

Apotekarsocieteten Clinical Pharmacology Strategies in Drug Development

Danielle PillsburyMarch 2, 2026

Conference

Marbach DDI Workshop 2026

CertaraFebruary 26, 2026

Announcement

Certara Launches DIDB® Concomitant Meds Navigator, Extending Leadership in Drug Interaction Science

Meet DIDB Concomitant Meds Navigator—an evidence-based tool to identify contraindicated or monitored co-medications and manage…

CertaraSeptember 22, 2025

Fact Sheet

Drug Interaction Database (DIDB ®)

Optimize DDI knowledge throughout drug development

CertaraSeptember 19, 2025

Announcement

Certara Launches Libra™: AI-Powered Drug-Induced Liver Injury Prediction Tool

RADNOR, Pa. – September 17, 2025 – Certara, Inc. (Nasdaq: CERT), a global leader in…

CertaraSeptember 17, 2025

Blog

Replacing Traditional TQT Studies with Model-Based Concentration-QTc (C-QTc) Analysis for Cardiovascular Safety in Drug Development

Learn how our experts use concentration-QTc (C-QTc) analysis to replace costly TQT studies, streamline QT…

CertaraAugust 6, 2025

Drug-Drug Interactions (DDI)

Population Pharmacokinetics and Exposure-Response Analysis of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia Patients With NPM1 Mutation

DIDB® Concomitant Meds Navigator

Regulatory horizons 2026: clinical pharmacology strategy and regulatory expectations

What is Simcyp Discovery and How Does it Support Drug Discovery?

Apotekarsocieteten Clinical Pharmacology Strategies in Drug Development

Marbach DDI Workshop 2026

Certara Launches DIDB® Concomitant Meds Navigator, Extending Leadership in Drug Interaction Science

Drug Interaction Database (DIDB ®)

Certara Launches Libra™: AI-Powered Drug-Induced Liver Injury Prediction Tool

Replacing Traditional TQT Studies with Model-Based Concentration-QTc (C-QTc) Analysis for Cardiovascular Safety in Drug Development

Newsletter sign up

Quick links

Solutions

Contact